Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2543
https://www.valueinhealthjournal.com/article/S1098-3015(14)04473-8/fulltext
Title :
Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04473-8&doi=10.1016/j.jval.2014.08.2543
First page :
A682
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1996